5 research outputs found
A Case of Perilla Allergy in a 2-Year-old Boy
Even though perilla is one of the most commonly consumed grain in Asia including Korea, perilla allergy is rare. A 2 year-old boy had erythematous popular urticaria on his whole body, as well as vomiting and diarrhea after ingestion of boiled perilla. On the second day of admission, old blood clots in the vomitus and blood tinged stool were shown. He underwent an esophago gastro duodenoscopy which showed a large duonenal ulcer. After treatment, his general condition improved. We report a case of perilla allergy with brief review of related literature.ope
μμ μ²μ νμμμ νμ² retinol-binding protein 4μ μμμ μλ―Έ
Dept. of Medicine/μμ¬[νκΈ]
λͺ©μ : μ΅κ·Ό μ²μκ³Ό λΉλ§μ μ λ³λ₯ μ΄ μ¦κ°νκ³ μμ΄ μ²μκ³Ό λΉλ§ μ¬μ΄μ μ°κ΄μ±μ λ°νκ³ μ νλ μ°κ΅¬κ° μ§μλκ³ μλ€. Retinol-binding protein (RBP) 4λ μ§λ°©μΈν¬(adipocyte)μμ λΆλΉλλ λ¬Όμ§λ‘μ μ΅κ·Ό λΉλ§ λ° λΉλ¨λ³κ³Ό λ°μ ν μ°κ΄μ΄ μλ κ²μΌλ‘ μλ €μ§κ³ μλ€. λ³Έ μ°κ΅¬μμλ λΉλ§κ³Ό κ΄λ ¨λ μ²μμ λ³μΈμ κ΄ν μ°κ΅¬μ μΌνμΌλ‘ μμ μ²μμμ RBP4μ μμλ₯Ό κ·λͺ
νκ³ μ νμμΌλ©°, μν νΌ μΈμ, νκΈ°λ₯ μ§ν λ° κΈ°κ΄μ§ κ³Όλ―Όμ±κ³Όμ μ°κ΄μ±μ λν΄ μμλ³΄κ³ μ νμλ€.λμ λ° λ°©λ² : λ§ 6μΈμμ 10μΈ μ¬μ΄μ 160λͺ
μ λμμΌλ‘ νμλ€. μ²μ νμλ 122λͺ
, λμ‘°κ΅°μ 38λͺ
μ΄μλ€. μ 체 λμμμμ νκΈ°λ₯ κ²μ¬, λ©νμ½λ¦° μ λ°μνμ μννμκ³ , νμ‘ μ΄νΈμ°κ΅¬μ, νμ² μ΄ IgE, eosinophil cationic protein(ECP), RBP4 λλ λ° ν€μ λͺΈλ¬΄κ²λ₯Ό μΈ‘μ νμλ€. Body mass index (BMI)λ₯Ό ꡬνμ¬ κ° μ±λ³, μ°λ Ήμ λ°λ₯Έ BMI λ°±λΆμμ 곑μ μ μ΄μ©νμ¬ BMI λ°±λΆμμλ₯Ό ꡬνμλ€.κ²°κ³Ό : μ 체 λμμμμ νμ² RBP4 λλλ μ²μκ΅°κ³Ό λμ‘°κ΅° μ¬μ΄μ μλ―Έμλ μ°¨μ΄λ₯Ό 보μ΄μ§ μμμΌλ©° λ κ΅° λͺ¨λμμ BMIμ κ΄λ ¨μ΄ μμλ€. μ 체 λμμμ μ¬μμμ νμ² RBP4 λλλ νμ‘ μ΄νΈμ°κ΅¬μ, νμ² μ΄ IgE, ECP λλ, νκΈ°λ₯ λ° PC20μ μ°κ΄μ±μ λνλ΄μ§ μμμΌλ λ¨μμμ νμ² RBP4 λλλ FEV1/FVC λ° FEF25%-75%μ μλ―Έμλ μκ΄κ΄κ³λ₯Ό 보μλ€.κ²°λ‘ : νμ² RBP4λ μ²μκ³Ό μ§μ μ μΈ κ΄λ ¨μ 보μ΄μ§ μμμΌλ, μ¬μΆκΈ° μ΄μ λ¨μμμ νκΈ°λ₯κ³Ό μ°κ΄μ±μ λνλ΄μλ€. μ΄λ μ¬μΆκΈ° μ΄μ μμμμμ μ²μ μ λ³λ₯ μ΄ λ¨μμμ μ¦κ°λμ΄ μλ κ²½ν₯μ κ°μ μ μΌλ‘ λ·λ°μΉ¨νλ κ²μΌλ‘ μ¬λ£λλ€.
[μλ¬Έ]
Aim : Recently the prevalence of both asthma and obesity have increased substantially in many countries. The aim of this study was to evaluate the role of retinol-binding protein 4 (RBP4) in childhood asthma and its association with atopy markers, pulmonary function, and bronchial hyperresponsiveness in relation to obesity.Methods : We studied 160 children aged 6 to 10 years old, including 122 asthmatics and 38 controls. The body mass index, pulmonary function tests, and methacholine challenge tests were measured on the same day. Total eosinophil count, total serum IgE, serum eosinophil cationic protein, and serum RBP4 were measured in all subjects.Results : There was no difference in serum RBP4 levels between asthmatics and the control group. In all subjects or subgroups, serum RBP4 did not associate with total eosinophil count, total serum IgE, serum eosinophil cationic protein, or PC20. There was no relationship between serum RBP4 and pulmonary function in female subjects. But, FEV1/FVC and FEF25-75% contributed to serum RBP4 in male subjects.Conclusion : Our findings show an association between RBP4 and pulmonary function in prepubertal males. This relationship may indirectly affect the high prevalence of childhood asthma in males.ope
Clinical Implication of Sputum CXCLl3 in Children with Asthma
Purpose: CXCL13 is known to be a chemokine delivering B cell to the secondary lymphatic follicles, such as spleen, lymph nodes, and Peyer`s patches. Recently, there have been some reports that CXCL13 is important for T cell inflammation and expressed by Th17 cell which produces IL-17. This study attempted to examine the clinical implication of CXCL13 in children with asthma. Methods: This study included a total of 160 children aged 6 to 15 years who visited Severance Children`s Hospital. There were 80 children with asthma and 80 children without. the pulmonary function test and the methacholine challenge test were performed. Total eosinophi1 count, eosinophil cationic protein (ECP) and total IgE in serum and eosinophils, ECP and CXCL13 in sputum were measured. Results: the mean age of the subjects was 8.3Β±2.3 years for the asthma group and 9.3Β±2.5 years for the control group. the male to female ratio was 67.5% and 55.0% respectively. the sputum CXCL13 level for the asthma group was significantly higher than that level for the control group (P=0.003). This significance persisted even after adjustment for age and sex (P=0.010). the sputum CXCL13 level showed a positive correlation with that of sputum eosinophils (r=0.190, P=0.017) and ECP (r=0.285, P=0.002). Conclusion: Our results suggest that CXCL13 may play an important role in the pathophysiology of asthma related to eosinophilic inflammation. Further studies on sputum CXCL13 could help to reveal the role of chemokines in asthmaope
μμ μ²μκ³Ό νΈμ°κ΅¬μ± κΈ°κ΄μ§μΌμμ νκ΄ λ΄νΌμΈν¬ μ±μ₯μΈμ(VEGF)μ μμ
Purpose: Vascular endothelial growth factor (VEGF) is an important mediator of airway inflammation and remodeling in asthma. We aimed to explore whether VEGF is expressed at elevated levels in asthmatic airways or eosinophilic bronchitis (EB) and associated with eosinophilic inflammation, pulmonary function, and airway hyperresponsiveness (AHR) in children. Methods: One hundred seventeen asthmatic children, 77 children with EB, and 84 healthy children were enrolled. Sputum supernatants were collected and VEGF and eosinophil cationic protein (ECP) levels were measured. Results: Asthmatic children had significantly higher levels of VEGF in induced sputum [89.04 (29.95-178.09) pg/mL] compared to children with EB [25.30 (11.02-80.23) pg/mL] and healthy children [37.37 (16.56-71.30) pg/mL; P=0.0003]. VEGF in sputum positively correlated with sputum ECP (r=0.524; P<0.0001). Negative significant correlations were found between sputum VEGF and FEV1, (r=-0.252; P=0.001) or post-bronchodilator FEV1 (r=-0.181; P=0.038) whereas nonsignificant correlations were found between sputum VEGF and sputum eosinophils. Conclusion: Our findings suggest that VEGF is associated with activated eosinophils in the asthmatic airway, but not EB. Sputum VEGF could be a supportive marker that represents activation of airway eosinophils and persistent airflow limitation in asthmatic children.ope
Relationship between amphiregulin and airway inflammation in children with asthma and eosinophilic bronchitis
BACKGROUND: Amphiregulin, a member of the epidermal growth factor family, has been shown to promote the growth of fibroblasts, to be associated with the T-helper type 2 cell adaptive immune response, and to up-regulate mucin gene expression. We aimed to determine whether sputum amphiregulin is expressed at elevated levels in patients with asthma or eosinophilic bronchitis (EB), and whether it is associated with eosinophilic inflammation, pulmonary function, and bronchial hyperresponsiveness in children.
METHODS: A total of 117 children with asthma, 77 with EB, and 84 control subjects were enrolled in this study. Amphiregulin and eosinophil cationic protein (ECP) levels were measured in sputum supernatants. We performed pulmonary function and methacholine challenge tests while measuring total eosinophil count, and serum levels of total IgE and ECP in all children.
RESULTS: The children with asthma had significantly higher levels of sputum amphiregulin (mean, 10.80 pg/mL; range, 4.07 to 38.75 pg/mL) than both the children with EB (mean, 5.76 pg/mL; range, 0.61 to 21.65 pg/mL; p = 0.013) and the control subjects (mean, 6.56 pg/mL; range, 0.51 to 17.98 pg/mL; p = 0.003). Sputum amphiregulin levels positively correlated with levels of sputum eosinophils (gamma = 0.221; p = 0.007) and sputum ECP (gamma = 0.601; p < 0.0001). Negative significant correlations were found between sputum amphiregulin and FEV(1) (gamma = -0.181; p = 0.006) or post-bronchodilator therapy FEV(1) (gamma = -0.233; p = 0.002). In children with asthma who were not receiving any controller medications, sputum amphiregulin level was negatively correlated with the provocative concentration of methacholine causing a 20% fall in FEV(1) (r = -0.398; p = 0.008).
CONCLUSIONS: Our findings suggest that childhood asthma is associated with sputum amphiregulin, whereas EB is not, and that sputum amphiregulin would be a supportive marker of airway inflammation in asthma.ope